Literature DB >> 15963709

Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection.

Padmini Salgame1.   

Abstract

It is clear that resistance against acute tuberculosis (TB) is dependent on the host's ability to generate Th1 immunity. Nevertheless, the role of host immunity in latent TB remains incompletely defined. Recent progress in elucidating host innate and adaptive immune responses to M. tuberculosis (Mtb) and their impact on latent infection includes identification of TLR2-dependent anti-inflammatory responses, a MyD88-independent, non-protective Th1 response, the formation of secondary lymphoid follicles in granulomas and the role of Th1 responses, IFN-gamma and TNF-alpha in preventing re-activation of infection; IFN-gamma also appears to be involved in activating latency genes in Mtb. When Mtb re-infects a patient, it appears to localize in established granulomas; however, different bacterial strains may behave differently. Although these advances do not provide all the answers regarding host defense mechanisms, they nevertheless bring us closer to new and better design strategies for immunotherapy and immunoprophylaxis.

Entities:  

Mesh:

Year:  2005        PMID: 15963709     DOI: 10.1016/j.coi.2005.06.006

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  66 in total

Review 1.  Immunomodulation by vitamin D: implications for TB.

Authors:  Rene F Chun; John S Adams; Martin Hewison
Journal:  Expert Rev Clin Pharmacol       Date:  2011-09       Impact factor: 5.045

2.  Improved detection of latent Mycobacterium tuberculosis infection in HIV-1 seropositive individuals using cultured cellular assays.

Authors:  Suzanne Campion; Myron S Cohen; Andrew J McMichael; Shannon Galvin; Nilu Goonetilleke
Journal:  Eur J Immunol       Date:  2010-12-01       Impact factor: 5.532

Review 3.  Mycobacterium tuberculosis, autoimmunity, and vitamin D.

Authors:  Yinon Shapira; Nancy Agmon-Levin; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 4.  Autophagy in the immune response to tuberculosis: clinical perspectives.

Authors:  C Ní Cheallaigh; J Keane; E C Lavelle; J C Hope; J Harris
Journal:  Clin Exp Immunol       Date:  2011-03-25       Impact factor: 4.330

5.  The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease.

Authors:  Masayuki Fukata; Keith Breglio; Anli Chen; Arunan S Vamadevan; Tyralee Goo; David Hsu; Daisy Conduah; Ruliang Xu; Maria T Abreu
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

6.  Protective heterologous immunity against fatal ehrlichiosis and lack of protection following homologous challenge.

Authors:  Nagaraja R Thirumalapura; Heather L Stevenson; David H Walker; Nahed Ismail
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

7.  Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys.

Authors:  Steven G Reed; Rhea N Coler; Wilfried Dalemans; Wilifred Dalemans; Esterlina V Tan; Eduardo C DeLa Cruz; Randall J Basaraba; Ian M Orme; Yasir A W Skeiky; Mark R Alderson; Karen D Cowgill; Jean-Paul Prieels; Rodolfo M Abalos; Marie-Claude Dubois; Joe Cohen; Pascal Mettens; Yves Lobet
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

8.  Helminth coinfection does not affect therapeutic effect of a DNA vaccine in mice harboring tuberculosis.

Authors:  Fabiani G Frantz; Rogério S Rosada; Camila Peres-Buzalaf; Franciele R T Perusso; Vanderlei Rodrigues; Simone G Ramos; Steven L Kunkel; Célio L Silva; Lúcia H Faccioli
Journal:  PLoS Negl Trop Dis       Date:  2010-06-08

9.  Human mucosal associated invariant T cells detect bacterially infected cells.

Authors:  Marielle C Gold; Stefania Cerri; Susan Smyk-Pearson; Meghan E Cansler; Todd M Vogt; Jacob Delepine; Ervina Winata; Gwendolyn M Swarbrick; Wei-Jen Chua; Yik Y L Yu; Olivier Lantz; Matthew S Cook; Megan D Null; David B Jacoby; Melanie J Harriff; Deborah A Lewinsohn; Ted H Hansen; David M Lewinsohn
Journal:  PLoS Biol       Date:  2010-06-29       Impact factor: 8.029

10.  Attenuation of toll-like receptor expression and function in latent tuberculosis by coexistent filarial infection with restoration following antifilarial chemotherapy.

Authors:  Subash Babu; Sajid Q Bhat; N Pavan Kumar; R Anuradha; Paul Kumaran; P G Gopi; C Kolappan; V Kumaraswami; Thomas B Nutman
Journal:  PLoS Negl Trop Dis       Date:  2009-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.